The Venous Thrombectomy Armamentarium: An Expanding World.

IF 0.8 Q4 SURGERY
Jason Storch, Justin M George, Christopher Hatzis, Jonathan Lee, Ajit Rao, Windsor Ting, Michael L Marin, Peter Faries, Rami O Tadros
{"title":"The Venous Thrombectomy Armamentarium: An Expanding World.","authors":"Jason Storch, Justin M George, Christopher Hatzis, Jonathan Lee, Ajit Rao, Windsor Ting, Michael L Marin, Peter Faries, Rami O Tadros","doi":"10.52198/23.STI.42.CV1676","DOIUrl":null,"url":null,"abstract":"<p><p>Acute deep venous thrombosis (DVT) is a common and important public health problem. It affects more than 350,000 people in the United States annually and has a substantial economic impact. Without adequate treatment, there is significant risk of development of post-thrombotic syndrome (PTS) resulting in patient morbidity, worse quality of life, and costly long-term medical care. Over the past decade, the treatment algorithm for patients with acute DVT has significantly changed. Prior to 2008, the treatment recommendation for patients with acute DVT was limited to anticoagulation and conservative management. In 2008, national clinical practice guidelines were updated to include interventional strategies such as surgical- and catheter-based techniques for the treatment of acute DVT. Early strategies for debulking of extensive acute DVT primarily consisted of open surgical thrombectomy and administration of thrombolytics. In the intervening period, a plethora of advanced endovascular techniques and technologies have been developed which reduced the morbidity of operative intervention and risks of hemorrhage associated with thrombolysis. This review will focus on the novel technologies commercially available for management of acute DVT, denoting unique features inherent to each device. This expanded armamentarium gives vascular surgeons and proceduralists the opportunity to individualize their treatment approach to the specific patient's anatomy, lesion, and history.</p>","PeriodicalId":22194,"journal":{"name":"Surgical technology international","volume":null,"pages":null},"PeriodicalIF":0.8000,"publicationDate":"2023-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgical technology international","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.52198/23.STI.42.CV1676","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

Abstract

Acute deep venous thrombosis (DVT) is a common and important public health problem. It affects more than 350,000 people in the United States annually and has a substantial economic impact. Without adequate treatment, there is significant risk of development of post-thrombotic syndrome (PTS) resulting in patient morbidity, worse quality of life, and costly long-term medical care. Over the past decade, the treatment algorithm for patients with acute DVT has significantly changed. Prior to 2008, the treatment recommendation for patients with acute DVT was limited to anticoagulation and conservative management. In 2008, national clinical practice guidelines were updated to include interventional strategies such as surgical- and catheter-based techniques for the treatment of acute DVT. Early strategies for debulking of extensive acute DVT primarily consisted of open surgical thrombectomy and administration of thrombolytics. In the intervening period, a plethora of advanced endovascular techniques and technologies have been developed which reduced the morbidity of operative intervention and risks of hemorrhage associated with thrombolysis. This review will focus on the novel technologies commercially available for management of acute DVT, denoting unique features inherent to each device. This expanded armamentarium gives vascular surgeons and proceduralists the opportunity to individualize their treatment approach to the specific patient's anatomy, lesion, and history.

静脉血栓切除术的武器库:不断扩展的世界。
急性深静脉血栓(DVT)是一个常见而重要的公共卫生问题。在美国,每年有超过 35 万人受到这种疾病的影响,并造成巨大的经济损失。如果不进行适当的治疗,很有可能发展成血栓后综合征(PTS),导致患者发病、生活质量下降和长期医疗费用昂贵。在过去十年中,急性深静脉血栓患者的治疗算法发生了重大变化。2008 年以前,急性深静脉血栓患者的治疗建议仅限于抗凝和保守治疗。2008 年,国家临床实践指南进行了更新,纳入了治疗急性深静脉血栓的介入策略,如外科手术和导管技术。早期治疗广泛急性深静脉血栓的方法主要包括开放手术血栓切除术和溶栓药物。在此期间,大量先进的血管内技术和科技应运而生,降低了手术干预的发病率和溶栓治疗带来的大出血风险。本综述将重点介绍市场上可用于治疗急性深静脉血栓的新型技术,并指出每种设备固有的独特功能。这些新技术使血管外科医生和手术医师有机会根据病人的具体解剖结构、病变和病史采取个性化的治疗方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.00
自引率
0.00%
发文量
141
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信